Document:

Registration Rights Agreement

 Exhibit 4.1 
  
 EXECUTION COPY 

 $350,000,000 
  
 3.25% CONVERTIBLE SENIOR NOTES DUE 2025 
  
 REGISTRATION RIGHTS AGREEMENT 
  
 DATED AS OF JUNE 20, 2005 
  
 by and among 
  
 INVITROGEN CORPORATION 
  
 and 
  
 UBS SECURITIES LLC 
  
 and 
  
 BANC OF AMERICA SECURITIES LLC 
  

 This Registration Rights Agreement (this “Agreement”) is made and entered into as
of June 20, 2005 by and among Invitrogen Corporation, a Delaware corporation (the “Company”), and UBS Securities LLC (“UBS”) and Banc of America Securities LLC (“BoA”) (each an “Initial
Purchaser” and together, the “Initial Purchasers”). The Company proposes to issue and sell to the Initial Purchasers (the “Initial Placement”) $325,000,000 in aggregate principal amount of
its 3.25% Convertible Senior Notes due 2025 (the “Firm Convertible Notes”). The Company also proposes to issue and sell to the Initial Purchasers not more than $25,000,000 in aggregate principal amount of its 3.25%
Convertible Senior Notes due 2025 (the “Additional Convertible Notes” and, together with the Firm Convertible Notes, the “Notes”) to cover over-allotments. As an inducement to the Initial Purchasers to
enter into the purchase agreement, dated as of June 14, 2005 (the “Purchase Agreement”), and in satisfaction of a condition to the Initial Purchasers’ obligations thereunder, the Company agrees with the Initial
Purchasers, (i) for the benefit of the Initial Purchasers and (ii) for the benefit of the holders from time to time of the Notes whose names appear in the register maintained by the Registrar in accordance with the provisions of the Indenture (as
defined in Section 1 hereof) (including the Initial Purchasers), as follows: 
  
 SECTION 1. DEFINITIONS 
  
 Capitalized terms used
herein without definition shall have their respective meanings set forth in the Purchase Agreement. As used in this Agreement, the following capitalized defined terms shall have the following meanings: 
  
 “Act” means the Securities Act of 1933, as amended,
and the rules and regulations of the Commission promulgated thereunder. 
  
 “Affiliate” of any specified person means any other person which, directly or indirectly, is in control of, is controlled by, or is under common control with, such specified person. For purposes of this definition,
control of a person means the power, direct or indirect, to direct or cause the direction of the management and policies of such person whether by contract or otherwise; and the terms “controlling” and “controlled” have meanings
correlative to the foregoing. 
  
 “Agreement” means this Registration Rights Agreement. 
  
 “Closing Date” has the meaning set forth in the Purchase Agreement. 
  
 “Commission” means the Securities and Exchange Commission. 
  
 “Common Stock” means the common stock of the Company, par value $0.01 per share, issuable upon the
conversion of the Notes. 
  
 “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder. 
  
 “Holder” has the meaning set forth in Section 2 hereof. 

 “Indenture” means the Indenture, dated as of June 20, 2005 between the Company
and the Trustee, relating to the Notes, as the same may be amended from time to time in accordance with the terms thereof. 
  
 “Initial Placement” has the meaning set forth in the preamble hereto. 
  
 “Majority Holders” means the Holders of a majority of
the aggregate principal amount of securities registered under a Shelf Registration Statement. 
  
 “Prospectus” means the prospectus included in any Shelf Registration Statement (including, without limitation, a prospectus that discloses information previously omitted from a prospectus filed
as part of an effective registration statement in reliance upon Rule 430A under the Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of Transfer Restricted Securities covered by
such Shelf Registration Statement, and all amendments and supplements to the Prospectus, including post-effective amendments. 
  
 “Shelf Registration” means a registration effected pursuant to Section 3 hereof. 
  
 “Shelf Registration Period” has the meaning set forth
in Section 3 hereof. 
  
 “Shelf Registration
Statement” means a “shelf” registration statement of the Company pursuant to the provisions of Section 3 hereof that covers some or all of the Transfer Restricted Securities as applicable, on an appropriate form under Rule 415
under the Act, or any similar rule that may be adopted by the Commission, amendments and supplements to such registration statement, including post-effective amendments, and in each case, including the Prospectus contained therein, all exhibits
thereto and all material incorporated therein by reference. 
  
 “Supplemental Delay Period” means any period commencing on the date of receipt by a Holder of Transfer Restricted Securities of any notice from the Company of the existence of any fact or event of the kind described
in Section 4(b)(2) hereof and ending on the date of receipt by such Holder of an amended or supplemented Shelf Registration Statement or Prospectus, as contemplated by Section 4(h) hereof, or the receipt by such Holder of written notice from the
Company (the “Advice”) that the use of the Prospectus may be resumed, and the receipt of copies of any additional or supplemental filings that are incorporated by reference in the Prospectus. 
  
 “Transfer Restricted Securities” means each Note and
the Common Stock issuable upon conversion thereof until (i) the date on which such Note or the Common Stock issuable upon conversion thereof has been effectively registered under the Act and disposed of in accordance with the Shelf Registration
Statement, (ii) the date on which such Note or Common Stock issuable upon conversion thereof is distributed to the public pursuant to Rule 144 under the Act (or any similar provision then in effect) or is salable pursuant to Rule 144(k) under the
Act or (iii) the date on which such Note or the Common Stock issuable upon conversion thereof ceases to be outstanding. 
  
 “Trustee” means the trustee with respect to the Notes under the Indenture. 
  

 2 

 “Underwriter” means any underwriter of Notes in connection with an offering
thereof under a Shelf Registration Statement. 
  
 SECTION 2. HOLDERS

  
 A person is deemed to be a holder of Transfer Restricted
Securities (each, a “Holder”) whenever such person becomes the registered holder of such Transfer Restricted Securities under the Indenture and includes broker-dealers that hold Transfer Restricted Securities (i) as a result
of market making activities and other trading activities and (ii) which were acquired directly from the Company or an Affiliate of the Company. 
  
 SECTION 3. SHELF REGISTRATION 
  
 The Company shall within 90 days of the date of original issuance of the Notes, file with the Commission and thereafter shall use its reasonable best
efforts to cause to be declared effective under the Act on or prior to 180 days (plus any additional days allowed as a result of a Supplemental Delay Period) after the date of original issuance of the Notes, a Shelf Registration Statement relating
to the offer and sale of the Transfer Restricted Securities by the Holders from time to time in accordance with the methods of distribution elected by such Holders and set forth in such Shelf Registration Statement. 
  
 The Company shall use its reasonable best efforts to keep the Shelf
Registration Statement continuously effective in order to permit the Prospectus forming part thereof to be usable by Holders for a period of two years from the date of original issuance of the Notes or such shorter period that will terminate when
(i) all the Transfer Restricted Securities covered by the Shelf Registration Statement have been sold pursuant to the Shelf Registration Statement, (ii) the date on which, in the opinion of counsel to the Company, all of the Transfer Restricted
Securities then held by the Holders may be sold by such Holders in the public United States securities markets in the absence of a registration statement covering such sales or (iii) the date on which there ceases to be outstanding any Transfer
Restricted Securities (in any such case, such period being called the “Shelf Registration Period”). The Company shall be deemed not to have used its reasonable best efforts to keep the Shelf Registration Statement effective
during the requisite period if it voluntarily takes any action that would result in Holders of Transfer Restricted Securities covered thereby not being able to offer and sell such securities during that period, unless (i) such action is required by
applicable law, (ii) such action is taken by the Company in good faith and for valid business reasons (not including avoidance of the Company’s obligations hereunder), including the acquisition or divestiture of assets, so long as the Company
promptly thereafter complies with the requirements of Section 4(h) hereof, if applicable or (iii) such action is taken because of any fact or circumstance giving rise to a Supplemental Delay Period. 
  

 3 

 SECTION 4. REGISTRATION PROCEDURES 
  
 In connection with any Shelf Registration Statement, the following provisions shall apply: 
  
 (a) The Company shall ensure that (i) any Shelf Registration Statement and
any amendment thereto and any Prospectus forming part thereof and any amendment or supplement thereto complies in all material respects with the Act and the rules and regulations thereunder, (ii) any Shelf Registration Statement and any amendment
thereto does not, when it becomes effective, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading and (iii) any Prospectus forming
part of any Shelf Registration Statement, and any amendment or supplement to such Prospectus, does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements, in the light of the
circumstances under which they were made, not misleading. 
  
 (b)
(1) The Company shall advise the Initial Purchasers and the Holders of Transfer Restricted Securities named in any Shelf Registration Statement that have provided in writing to the Company a telephone or facsimile number and address for notices,
and, if requested by the Initial Purchasers or any such Holder, confirm such advice in writing when a Shelf Registration Statement and any amendment thereto has been filed with the Commission and when the Shelf Registration Statement or any
post-effective amendment thereto has become effective. 
  
 (2) The
Company shall advise the Initial Purchasers and the Holders of Transfer Restricted Securities named in any Shelf Registration Statement, which have provided in writing to the Company a telephone or facsimile number and address for notices, and, if
requested by the Initial Purchasers or any such Holder, confirm such advice in writing: 
  
 (i) of any request by the Commission for amendments or supplements to the Shelf Registration Statement or the Prospectus included therein
or for additional information; 
  
 (ii) of the
initiation by the Commission of proceedings relating to a stop order suspending the effectiveness of the Shelf Registration Statement; 
  
 (iii) of the issuance by the Commission of any stop order suspending the effectiveness of the Shelf Registration Statement; 
  
 (iv) of the receipt by the Company of any notification with
respect to the suspension of the qualification of the securities included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and 
  
 (v) of the existence of any fact and the happening of any event that, in the opinion of the Company, makes
untrue any statement of a material fact made in its Shelf Registration Statement, the Prospectus or any amendment or supplement thereto or any document incorporated by reference therein or requires the making of any changes in the Shelf Registration
Statement or the Prospectus so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of the Prospectus, in
light of the circumstances under which they were made) not misleading. 
  

 4 

 Such advice may be accompanied by an instruction to suspend the use of the Prospectus until the requisite
changes have been made. 
  
 (c) The Company shall use its best
efforts to obtain the withdrawal of any order suspending the effectiveness of any Shelf Registration Statement at the earliest possible time. 
  
 (d) The Company shall use its best efforts to furnish to each selling Holder named in any Shelf Registration Statement who so requests in writing and who
has provided to the Company an address for notices, without charge, at least one conformed copy of such Shelf Registration Statement and any post-effective amendment thereto, including financial statements and, if the Holder so requests in writing,
all exhibits and schedules (including those incorporated by reference). 
  
 (e) The Company shall, during the Shelf Registration Period, deliver to each Holder of Transfer Restricted Securities named in any Shelf Registration Statement and who has provided to the Company an address for notices, without charge, as
many copies of the Prospectus (including each preliminary Prospectus) contained in such Shelf Registration Statement and any amendment or supplement thereto as such Holder may reasonably request; subject to any notice by the Company in accordance
with Section 5(b) hereof, the Company consents to the use of the Prospectus or any amendment or supplement thereto by each of the selling Holders for the purposes of offering and resale of the Transfer Restricted Securities covered by the Prospectus
in accordance with the applicable regulations promulgated under the Act. 
  
 (f) Prior to any offering of Transfer Restricted Securities pursuant to any Shelf Registration Statement, the Company shall register or qualify or cooperate with the Holders of Transfer Restricted Securities named
therein and their respective counsel in connection with the registration or qualification of such Transfer Restricted Securities for offer and sale under the securities or blue sky laws of such jurisdictions of the United States as any such Holders
reasonably request in writing not later than the date that is five business days prior to the date upon which this Agreement specifies that the Shelf Registration Statement shall become effective; provided, however, that the Company will not
be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to take any action which would subject it to general or unlimited service of process or to taxation in any such jurisdiction where it is not
then so subject. 
  
 (g) The Company shall endeavor to cooperate
with the Holders of Transfer Restricted Securities to facilitate the timely preparation and delivery of certificates representing Transfer Restricted Securities to be sold pursuant to any Shelf Registration Statement free of any restrictive legends
and in such denominations and registered in such names as Holders may request in writing at least two business days prior to sales of securities pursuant to such Shelf Registration Statement. 
  
 (h) Subject to Section 4(l), upon the occurrence of any event contemplated by
Section 4(b)(2)(v) hereof, the Company shall promptly prepare a post-effective amendment to any Shelf Registration Statement or an amendment or supplement to the related Prospectus or file any other required document so that as thereafter delivered
to purchasers of the Transfer Restricted 

  

 5 

 
Securities covered thereby, the Prospectus will not include an untrue statement of a material fact or omit to state any material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that in the event of a material business transaction (including, without limitation, pending negotiations relating to such a
transaction) which would, in the opinion of counsel to the Company, require disclosure by the Company in the Shelf Registration Statement of material non-public information for which the Company has a bona fide business purpose for not disclosing,
then for so long as such circumstances exist, the Company shall not be required to prepare and file a supplement or post-effective amendment hereunder. 
  
 (i) Not later than the effective date of any such Shelf Registration Statement hereunder, the Company shall cause to be provided a CUSIP number for the
Notes registered under such Shelf Registration Statement, and provide the applicable trustee with certificates for such Notes in a form eligible for deposit with The Depository Trust Company. 
  
 (j) During the twelve-month period commencing after effectiveness of the
Shelf Registration Statement, the Company shall make generally available to its security holders in a regular filing on Form 10-Q or 10-K an earnings statement satisfying the provisions of Rule 158 (which need not be audited). 
  
 (k) The Company shall cause the Indenture to be qualified under the Trust
Indenture Act in a timely manner. 
  
 (l) The Company may require
each Holder of Transfer Restricted Securities, which are to be sold pursuant to any Shelf Registration Statement, to furnish to the Company within 20 business days after written request for such information has been made by the Company, such
information regarding the Holder and the distribution of such securities as the Company may from time to time reasonably require for inclusion in such Shelf Registration Statement and such other information as may be necessary or advisable in the
reasonable opinion of the Company and its counsel, in connection with such Shelf Registration Statement. No Holder of Transfer Restricted Securities shall be entitled to the benefit of any Special Interest (as set forth in the Notes) under the
Indenture and the Notes or be entitled to use the Prospectus unless and until such Holder shall have furnished the information required by this Section 4(l) and all such information required to be disclosed in order to make the information
previously furnished to the Company by such Holder not materially misleading. For the purposes of this Section 4(l), upon receipt of information regarding a Holder requiring the filing of a supplement or amendment to the Prospectus, the Company
shall be required to so amend or supplement the Prospectus within five (5) business days from the earlier to occur of: (i) Holders holding at least $5 million in face value of Notes having provided information requiring the filing of such an
amendment or supplement, or (ii) fifteen (15) business days having elapsed from the receipt of such information. Notwithstanding the foregoing, the Company shall not be obligated to amend the Prospectus pursuant to a post-effective amendment to the
Shelf Registration Statement more than once in any 90 day period following the effective date of the Shelf Registration Statement. 
  
 (m) The Company shall, if requested, promptly incorporate in a Prospectus supplement or post-effective amendment to a Shelf Registration Statement, such
information as the Majority Holders reasonably agree should be included therein in order to effect their 

  

 6 

 
distribution of the Notes and shall make all required filings of such Prospectus supplement or post-effective amendment as soon as notified of the matters to
be incorporated in such Prospectus supplement or post-effective amendment; provided, however, that the Company shall not be required to take any action pursuant to this Section 4(m) that would, in the opinion of counsel for the Company,
violate applicable law or to include information the disclosure of which at the time would have a material adverse effect on the business or operations of the Company and/or its subsidiaries, as determined in good faith by the Company. 

 
 (n) The Company shall enter into such agreements and take all other
reasonably appropriate actions in order to expedite or facilitate the registration or the disposition of the Transfer Restricted Securities, and in connection therewith, if an underwriting agreement is entered into, cause the same to contain
indemnification and contribution provisions and procedures no less favorable than those set forth in Section 7 (or such other provisions and procedures acceptable to the Majority Holders), with respect to all parties to be indemnified pursuant to
Section 7. 
  
 (o) The Company shall upon receipt of a reasonable
request in writing therefor: 
  
 (i) make
reasonably available at reasonable times prior to the effectiveness of the related Shelf Registration Statement for inspection by representatives of the Holders of Transfer Restricted Securities to be registered thereunder and any attorney,
accountant or other agent retained by such Holders, at the office where normally kept during normal business hours, all financial and other records, pertinent corporate documents and properties of the Company and its subsidiaries, and cause the
Company’s officers, directors and employees to supply all relevant information reasonably requested by the Holders’ attorneys, accountants or other agents in connection with any such Shelf Registration Statement as is customary for similar
due diligence examinations; provided, however, that the foregoing inspection and information gathering shall be coordinated by one counsel designated by the Holders and that such persons shall first agree in writing with the Company that any
information that is designated in writing by the Company, in good faith, as confidential at the time of delivery of such information shall be kept confidential by such person, unless such disclosure is made in connection with a court proceeding or
required by law, or such information becomes available to the public generally or through a third party without an accompanying obligation of confidentiality; 
  

(ii) obtain opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be
reasonably satisfactory to the Majority Holders), addressed to each selling Holder named in the Shelf Registration Statement covering such matters (in form, scope and substance) as those matters set forth in Section 9(e) of the Purchase Agreement;

  
 (iii) obtain “cold comfort” letters
(or, in the case of any person that does not satisfy the conditions for receipt of a “cold comfort” letter specified in Statement on Auditing Standards No. 72, an “agreed-upon procedures letter”) and updates thereof from the
independent certified public accountants of the Company (and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements and financial
data are, 

  

 7 

 
or are required to be, included in the Shelf Registration Statement), addressed to each selling Holder of Transfer Restricted Securities registered
thereunder and the underwriters, if any, in customary form and covering matters of the type customarily covered in “cold comfort” letters in connection with primary underwritten offerings; and 
  
 (iv) deliver such documents and certificates as may be
reasonably requested by the Majority Holders, including those to evidence compliance with Section 4(h). 
  
 The foregoing actions set forth in clauses (ii), (iii) and (iv) of this Section 4(o) shall be performed upon the effectiveness of such Shelf Registration
Statement and the effectiveness of each post-effective amendment thereto. 
  
 (p) The Company may offer securities of the Company other than the Notes under the Shelf Registration Statement, except where such offer would conflict with the terms of the Purchase Agreement. 
  
 SECTION 5. HOLDERS’ AGREEMENTS 
  
 Each Holder of Transfer Restricted Securities severally but not jointly, by
the acquisition of such Transfer Restricted Securities, agrees: 
  
 (a) To furnish the information required to be furnished pursuant to Section 4(l) hereof within the time period set forth therein. 
  
 (b) That upon receipt of a notice of the commencement of a Supplemental Delay Period, it will keep the fact and content of such notice confidential,
forthwith discontinue disposition of its Transfer Restricted Securities pursuant to the Shelf Registration Statement, and will not deliver any Prospectus forming a part thereof until receipt of the amended or supplemented Shelf Registration
Statement or Prospectus, as applicable, as contemplated by Section 4(h) hereof, or until receipt of the Advice. If a Supplemental Delay Period should occur, the Shelf Registration Period shall be extended by the number of days of which the
Supplemental Delay Period is comprised; provided that the Shelf Registration Period shall not be extended if the Company has received an opinion of counsel (which counsel, if different from counsel to the Company referred to in Section 9(e)
of the Purchase Agreement, shall be reasonably satisfactory to the Majority Holders of the Transfer Restricted Securities named in the Shelf Registration Period and which opinion shall be in writing) to the effect that the Transfer Restricted
Securities can be freely tradable without the continued effectiveness of the Shelf Registration Statement. 
  
 (c) If so directed by the Company in a notice of the commencement of a Supplemental Delay Period, each Holder of Transfer Restricted Securities will
deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus covering the Transfer Restricted Securities. 
  
 (d) Sales of such Transfer Restricted Securities pursuant to a Shelf
Registration Statement shall only be made in the manner set forth in such currently effective Shelf Registration Statement. 
  

 8 

 SECTION 6. REGISTRATION EXPENSES 
  
 The Company shall bear all expenses incurred in connection with the performance of its obligations under Sections 3 and 4
hereof and will reimburse the Holders for the reasonable fees and disbursements of one firm or counsel designated by the Majority Holders to act as counsel for the Holders in connection with any Shelf Registration Statement. Notwithstanding the
foregoing or anything in this Agreement to the contrary, each Holder shall pay all underwriting discounts and commission of any underwriters with respect to any Transfer Restricted Securities sold by it. 
  
 SECTION 7. INDEMNIFICATION AND CONTRIBUTION 
  
 (a) The Company agrees to indemnify and hold harmless each Holder and each
person, if any, who controls such Holder within the meaning of the Act or the Exchange Act (each Holder, and such controlling persons are referred to collectively as the “Indemnified Parties”) from and against any losses, claims, damages
or liabilities, joint or several, or any actions in respect thereof (including, but not limited to, any losses, claims, damages, liabilities or actions relating to purchases and sales of the Securities) to which each Indemnified Party may become
subject under the Act, the Exchange Act or otherwise, insofar as such losses, claims, damages, liabilities or actions arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Shelf
Registration Statement or Prospectus including any document incorporated by reference therein, or in any amendment or supplement thereto or in any preliminary prospectus relating to the Shelf Registration, or arise out of, or are based upon, the
omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse, as incurred, the Indemnified Parties for any legal or other expenses
reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action in respect thereof; provided, however, that (i) the Company shall not be liable in any such case to the extent
that such loss, claim, damage or liability arises out of or is based upon any untrue statement or alleged untrue statement or omission or alleged omission made in the Shelf Registration Statement or Prospectus or in any amendment or supplement
thereto or in any preliminary prospectus relating to the Shelf Registration in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Holder specifically for inclusion therein and (ii) with respect
to any untrue statement or omission or alleged untrue statement or omission made in any preliminary prospectus relating to the Shelf Registration Statement, the indemnity agreement contained in this subsection (a) shall not inure to the benefit of
any Holder from whom the person asserting any such losses, claims, damages or liabilities purchased the securities concerned, to the extent that a prospectus relating to such securities was required to be delivered by such Holder under the Act in
connection with such purchase and any such loss, claim, damage or liability of such Holder results from the fact that there was not sent or given to such person, at or prior to the written confirmation of the sale of such securities to such person,
a copy of the final Prospectus if the Company had previously furnished copies thereof to such Holder; provided further, however, that this indemnity agreement will be in addition to any liability which the Company may otherwise
have to such Indemnified Party. The Company shall also indemnify underwriters, their officers and directors and each person who controls such underwriters within the meaning of the Act or the Exchange Act to the same extent as provided above with
respect to the indemnification of the Holders if requested by such Holders. 
  

 9 

 (b) Each Holder, severally and not jointly, will indemnify and hold harmless the Company, its officers
and directors and each person, if any, who controls the Company within the meaning of the Act or the Exchange Act from and against any losses, claims, damages or liabilities or any actions in respect thereof, to which the Company or any such
controlling person may become subject under the Act, the Exchange Act or otherwise, insofar as such losses, claims, damages, liabilities or actions arise out of or are based upon any untrue statement or alleged untrue statement of a material fact
contained in the Shelf Registration Statement or Prospectus or in any amendment or supplement thereto or in any preliminary prospectus relating to the Shelf Registration, or arise out of or are based upon the omission or alleged omission to state
therein a material fact necessary to make the statements therein not misleading, but in each case only to the extent that the untrue statement or omission or alleged untrue statement or omission was made in reliance upon and in conformity with
written information furnished to the Company by or on behalf of such Holder specifically for inclusion therein; and, subject to the limitation set forth immediately preceding this clause, shall reimburse, as incurred, the Company for any legal or
other expenses reasonably incurred by the Company or any such controlling person in connection with investigating or defending any loss, claim, damage, liability or action in respect thereof. This indemnity agreement will be in addition to any
liability which such Holder may otherwise have to the Company or any of its controlling persons. 
  
 (c) Promptly after receipt by an indemnified party under this Section 7 of notice of the commencement of any action or proceeding (including a
governmental investigation), such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 7, notify the indemnifying party of the commencement thereof; but the omission so to notify the
indemnifying party will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above. In case any such action is brought against any
indemnified party, and it notifies the indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, jointly with any other indemnifying party similarly notified,
to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), and after notice from the indemnifying party to
such indemnified party of its election so to assume the defense thereof the indemnifying party will not be liable to such indemnified party under this Section 7 for any legal or other expenses, other than reasonable costs of investigation,
subsequently incurred by such indemnified party in connection with the defense thereof. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened action in respect of
which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party unless such settlement (i) includes an unconditional release of such indemnified party from all liability on any
claims that are the subject matter of such action, and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. 
  

 10 

 (d) If the indemnification provided for in this Section 7 is unavailable or insufficient to hold harmless
an indemnified party under subsections (a) or (b) above, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof)
referred to in subsection (a) or (b) above in such proportion as is appropriate to reflect the relative fault of the indemnifying party or parties on the one hand and the indemnified party on the other in connection with the statements or omissions
that resulted in such losses, claims, damages or liabilities (or actions in respect thereof) as well as any other relevant equitable considerations. The relative fault of the parties shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or such Holder or such other indemnified party, as the case may be,
on the other, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities
referred to in the first sentence of this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any action or claim which is the subject of
this subsection (d). Notwithstanding any other provision of this Section 7(d), the Holders shall not be required to contribute any amount in excess of the amount by which the net proceeds received by such Holders from the sale of the securities
pursuant to the Shelf Registration Statement exceeds the amount of damages which such Holders have otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this paragraph (d), each person, if any, who controls such
indemnified party within the meaning of the Act or the Exchange Act shall have the same rights to contribution as such indemnified party and each person, if any, who controls the Company within the meaning of the Act or the Exchange Act shall have
the same rights to contribution as the Company. 
  
 (e) The
agreements contained in this Section 7 shall survive the sale of the securities pursuant to the Shelf Registration Statement and shall remain in full force and effect, regardless of any termination or cancellation of this Agreement or any
investigation made by or on behalf of any indemnified party. 
  
 SECTION 8.
RULE 144A AND RULE 144 
  
 The Company agrees with each
Holder, for so long as any Transfer Restricted Securities remain outstanding and during any period in which the Company (i) is not subject to Section 13 or 15(d) of the Exchange Act, to make available, upon request of any Holder, to such Holder or
beneficial owner of Transfer Restricted Securities in connection with any sale thereof and any prospective purchaser of such Transfer Restricted Securities designated by such Holder or beneficial owner, the information required by Rule 144A(d)(4)
under the Act in order to permit resales of such Transfer Restricted Securities pursuant to Rule 144A, and (ii) is subject to Section 13 or 15 (d) of the Exchange Act, to make all filings required thereby in a timely manner in order to permit
resales of such Transfer Restricted Securities pursuant to Rule 144. 
  

 11 

 SECTION 9. MISCELLANEOUS 
  

(a) No Inconsistent Agreements. The Company has not, as of the date hereof, entered into, nor shall it, on or after the date hereof, enter into,
any agreement with respect to its securities that is inconsistent with the rights granted to the Holders herein or otherwise conflicts with the provisions hereof. 
  
 (b) Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be
amended, qualified, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the Company has obtained the written consent of the Holders of at least a majority of the then outstanding
aggregate principal amount of Notes; provided, however, that with respect to any matter that directly or indirectly affects the rights of any Initial Purchaser hereunder, the Company shall obtain the written consent of each such Initial
Purchaser against which such amendment, qualification, supplement, waiver or consent is to be effective. Notwithstanding the foregoing (except the foregoing proviso), a waiver or consent to depart from the provisions hereof, with respect to a
matter, which relates exclusively to the rights of Holders whose securities are being sold pursuant to a Shelf Registration Statement and does not directly or indirectly affect the rights of other Holders, may be given by the Majority Holders,
determined on the basis of Notes being sold rather than registered under such Shelf Registration Statement. 
  
 (c) Notices. All notices and other communications provided for or permitted hereunder shall be made in writing by hand-delivery, first-class mail,
telex, telecopier, or air courier guaranteeing overnight delivery: 
  
 (i) if to a Holder, at the most current address given by such holder to the Company in accordance with the provisions of this Section 9(c), which address initially is, with respect to each Holder, the address of such
Holder maintained by the registrar under the Indenture; 
  
 (ii) with a copy in like manner to UBS Securities LLC; 
  
 (iii) if to the Initial Purchasers, initially at the respective addresses set forth in the Purchase Agreement; and 
  
 (iv) if to the Company, initially at its address set forth
in the Purchase Agreement. 
  
 All such notices and communications
shall be deemed to have been duly given when received. 
  
 Upon
the date of filing of a Shelf Registration Statement notice shall be delivered to UBS Securities LLC on behalf of the Initial Purchasers (in the form attached hereto as Exhibit A) and shall be addressed to: Attention: Syndicate Department, 299 Park
Avenue, New York, New York 10171. 
  
 The Initial Purchasers or
the Company by notice to the other may designate additional or different addresses for subsequent notices or communications. 
  

 12 

 (d) Successors and Assigns. This Agreement shall inure to the benefit of, and be binding upon, the
successors and assigns of each of the parties hereto, including, without the need for an express assignment or any consent by the Company thereto, subsequent Holders of Notes. The Company hereby agrees to extend the benefits of this Agreement to any
Holder of Notes and any such Holder may specifically enforce the provisions of this Agreement as if an original party hereto. 
  
 (e) Counterparts. This agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original, and all of which taken together shall constitute one and the same agreement. 
  
 (f) Headings. The headings in this agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

  
 (g) Governing Law. This agreement shall be governed by
and construed in accordance with the internal laws of the State of New York applicable to agreements made and to be performed in said State (without reference to the conflict of law rules thereof). 
  
 (h) Severability. In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstances, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and the remaining
provisions hereof shall not be in any way impaired or affected thereby, it being intended that all of the rights and privileges of the parties shall be enforceable to the fullest extent permitted by law. 
  
 (i) Notes Held by the Company, etc. Whenever the consent or approval
of Holders of a specified percentage of principal amount of Notes is required hereunder, Notes held by the Company or its Affiliates (other than subsequent Holders of Notes if such subsequent Holders are deemed to be Affiliates solely by reason of
their holdings of such Notes) shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage. 
  
 (j) Entire Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a complete and
exclusive statement of the agreement and understanding of the parties hereto with respect to the subject matter contained herein. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein with
respect to the registration rights granted with respect to the Transfer Restricted Securities. This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject matter. 
  
 (k) Waiver of Jury Trial. EACH OF UBS (ON BEHALF OF THE INITIAL
PURCHASERS) AND THE COMPANY (ON ITS BEHALF AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS STOCKHOLDERS AND AFFILIATES) WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED UPON CONTRACT, TORT
OR OTHERWISE) IN ANY WAY ARISING OUT OF OR RELATING TO THIS AGREEMENT. 
  

 13 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	COMPANY
	
	INVITROGEN CORPORATION
		
	By:	 	 /s/ John A. Cottingham

	Name:	 	John A. Cottingham
	Title:	 	Senior Vice President, General Counsel & Secretary
	
	INITIAL PURCHASERS
	
	UBS SECURITIES LLC
	BANC OF AMERICA SECURITIES LLC
		
	By:	 	UBS SECURITIES LLC
		
	By:	 	 /s/ Steven Meehan

	Name:	 	Steven Meehan
	Title:	 	Managing Director
		
	By:	 	 /s/ Dustin Tyner

	Name:	 	Dustin Tyner
	Title:	 	Associate Director

  
 [Signature Page
to Registration Rights Agreement] 

 EXHIBIT A 
  
 NOTICE OF FILING OF 
 SHELF REGISTRATION STATEMENT 
  

			
	To:	 	 UBS Securities LLC
 299 Park Avenue
 New York, New York 10171
 Attention:
                                
 Fax: (212)         
-                

		
	From:	 	 Invitrogen Corporation
 3.25% Convertible Senior Notes
due 2025

		
	Date:	 	                    , 200  
		
	 	 	For your information only (NO ACTION REQUIRED):

  
 Today,
                    , 200  , we filed a Shelf Registration Statement with the Securities and Exchange Commission.Employment Agreement dated April 1, 2005

 Exhibit 10.30 
  
 EMPLOYMENT AGREEMENT 
  

This Agreement shall be effective as of April 1, 2005 (The “Effective date”) by and between Daisy S. Chin-Lor (the “Executive”) and
Mayor’s Jewelers, Inc., a Delaware corporation (the “Company”). 
  
 WHEREAS, the Executive declares not being prevented from working as such in the United States and Canada; 
  
 NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements, the parties agree as follows: 
  

	Position,	Responsibilities and Term of Agreement 

  
 1.1 Employment and Duties. Subject to the terms and conditions of this Agreement, the Company employs the Executive to serve as the Senior Vice
President and Chief Marketing Officer reporting to the President and CEO and the Executive accepts such employment and agrees to perform in a diligent, careful and proper manner such reasonable responsibilities and duties commensurate with such
position as may be assigned to the Executive. The title and responsibilities and duties may be changed from time to time so long as it is consistent with her skills and expertise and the Executive continues to be a member of the Senior Management
team. Executive agrees to devote substantially all business time and efforts to and give undivided loyalty to the Company. 
  
 1.2 Place of work: The Executive shall reside in South Florida and provide her services to the Company primarily in Florida and Canada on a full
time and exclusive basis. Travel to Canada will be required approximately 40% of the time. 
  
 1.3 Effective Date. Subject to the provisions of this Agreement, this Agreement shall start as of April 1, 2005 (“Effective Date”) and shall continue (the “Term”) unless otherwise terminated
as provided for in this Agreement. 
  
 2. Compensation 
  
 2.1 Base Salary. During the term of this Agreement, the Company shall
pay the Executive an annual gross base salary of $250,000 less all applicable deductions, taxes, and withholdings, payable in the manner dictated by the Company’s standard payroll policies. The Executive shall be eligible to receive annual base
salary increases as consistent with other members of the Senior Management team determined at the Company’s discretion based upon the Executive’s performance and the Company’s performance. 
  
 2.2 Incentive Compensation 
  
 “Fiscal Year” in this Agreement shall mean such period of approximately 12 months
defined as such from time to time by the Company’s Board of Directors. The first Fiscal Year is from March 27, 2005, to March 25, 2006. 
  
 a) Annual Cash Bonus. For each Fiscal Year of the Company through which the Executive remains an active employee of the Company, the Executive will
have the opportunity to earn a bonus based on achievement of a targeted level of performance, as reflected in the annual bonus letter and based on performance criteria set by the Company. For the Fiscal Year ending March 25, 2006, and each Fiscal
Year thereafter, the target bonus is 35 % of the Base Salary. The minimum bonus pay out for any Fiscal Year is $0 and the maximum bonus pay out for any Fiscal Year is the maximum allowed under the then current Management Bonus Plan. For the Fiscal
Year ending March 25, 2006, the Executive will be guaranteed a portion of her annual cash bonus in the amount of $25,000 provided that the Executive remains an active employee through June 30th 2006. 

 b) Long-term Incentive Awards. For each Fiscal Year of the Company through which the Executive
remains an active employee of the Company, the Executive may be considered for a long-term incentive award of Mayor’s units subject to the approval of the Board of Directors and subject to any specific conditions as may be stated by the Board
of Directors and-or the Long-Term Incentive Plan. This award, if granted, will vest over a multi-year period as may be approved by the Board of Directors or stated in the Long-Term Incentive Plan. For the Fiscal Year ending March 25, 2006 the
Executive will be granted the equivalent of 50,000 Mayors units (whether stock options, SAR’s, phantom stock, etc,) with a 3 year vesting period. The pricing of these units will be subject to the earlier of the following two events: approval by
the Board of Directors or as soon as possible once The Board of Directors can approve such grant once the financial reorganization of Birks and Mayors is completed and the Company is authorized to grant Long Term Equity.  
  
 2.3 Participation in Benefit Plans and Associate Discount Policy. If
acceptable by the Company’s group insurers, the Company will provide the Executive with the group insurance coverages, currently including life, dental and medical insurance benefits, the cost of which shall be borne by the Company according to
the prevailing policies applicable to other Senior Management members. The Executive will also be provided an additional annual benefit payment in the amount of $15,000, paid on a quarterly basis. In addition, the Executive will be entitled to
participate in the Company’s Associate Discount Policy. The Company may, at its discretion, modify said policies from time to time. Nothing paid to the Executive under any plan, policies or arrangement presently in effect or made available in
the future shall be deemed to be in lieu of other compensation to the Executive hereunder as described in this Section 3. 
  
 2.4 Vacation Days. The Executive shall be entitled to twenty days of vacation for each Fiscal Year consistent with the Company’s vacation
policy for Senior Management officers. The vacation days are earned for a given Fiscal Year during that same Fiscal Year; as a result, for any portion of a Fiscal Year worked, the vacation shall be prorated on the basis of the number of days worked
during the Fiscal Year. Unused vacation days may not be carried over from year to year.  
  
 2.5 Expenses. During the term of employment hereunder, the Executive shall be entitled, without duplication, to receive reimbursement for all
reasonable and approved business expenses incurred by the Executive in accordance with the policies and procedures established by the Company. In addition but without duplication, the Executive shall receive the following allowances: 
  
 a) Car Allowance: The Executive shall be entitled to a car allowance gross
all-inclusive lump sum amount equal to $800 per month in accordance with the car allowance policy applicable to other members of Senior Management as may be amended from time to time. Any other automobile costs or expenses including, without
limitation, maintenance, insurance, repairs, lease or financing costs, and mileage, are the sole responsibility of the Executive. 
  
 b) Living Allowance: The Executive shall be entitled to a living allowance gross all-inclusive sum equal to $3,000 per month. 
  
 c) Relocation Allowance: The Executive will be provided a one-time relocation
allowance for her move to Florida as follows; Mayors will select a moving company, based upon submitted proposals, for handling the relocation of all household goods and Mayors will pay the moving company directly. The Company will also pay the
Executive a maximum of $10,000 for the purchase of household related items as such as blinds, carpets, etc. (gross all-inclusive), a maximum of $11,000 for costs related to the closing costs for the purchase of her Florida residence excluding points
paid for financing. The closing costs paid by the Executive will be grossed-up for tax purposes for the items that are not tax deductible. 
  
 d) Legal Allowance: The Executive will be provided a one-time allowance of up to $1,000 for the legal costs related to the review of this employment
agreement. 
  
 e) During the transition period to South Florida
until the Executive completes the sale of her property and relocation to Florida, for a period of up to six (6) months following the start date of employment and if longer to a period agreed by the President & CEO, the commuting expenses between
New York and Florida and/or Canada will be reimbursed by the Company in accordance with the travel policies and procedures of the Company. During the transition period, the Executive agrees to make their best effort to make all the necessary steps
to complete the relocation to Florida. . 
  
 It is understood that to the extent
these provisions generate taxable benefit for income tax purposes, these taxes will be the sole responsibility of the Executive. 

 3. Termination 
  
 3.1 Certain Definitions. For purposes of this Agreement, the following terms have the meanings indicated: 
  
 a) “Cause” shall mean: (i) the willful and continued failure by
the Executive to substantially perform the Executive’s duties for the Company (other than any such failure resulting from the Executive’s incapacity due to physical or mental illness, or any such actual or anticipated failure after the
Executive announces her intention to resign for Good Reason), (ii) the willful engaging by the Executive in misconduct which is financially injurious to the Company, or (iii) the Executive’s conviction or a pleading of guilty or nolo contendre
with respect to the commission of a felony or a crime involving bad faith or dishonesty; (iv) the Executive’s insubordination as determined by the superior and an appropriate third party.; (v) any breach by the Executive of any material term of
this Agreement or any other written agreement between the Executive and the Company; or (vi) the Executive’s material violation of any of the Company’s policies. No act, or failure to act, on the Executive’s part shall be considered
“willful” unless done, or omitted to be done, by the Executive not in good faith and without reasonable belief that the action or omission was in the best interest of the Company. 
  
 b) “Code” shall mean the Internal Revenue Code of 1986, as amended.

  
 c) “Disability” shall mean the Executive’s
inability to perform the Executive’s duties by reason of mental or physical disability for at least ninety (90) days in any three-hundred sixty-five (365) day period. In the event of a dispute as to whether the Executive is disabled within the
meaning hereof, either party may from time to time request a medical examination of the Executive by a doctor appointed by the Chief of Staff of a hospital selected by mutual agreement of the parties, or as the parties may otherwise agree, and the
written medical opinion of such doctor shall be conclusive and binding upon the parties as to whether the Executive has become disabled and the date when such disability arose. The cost of any such medical examination shall be borne by the Company.

  
 d) “Good Reason” shall mean (i) the Executive ceases
to be a member of the Senior Management of the Company, or (ii) the Company materially breaches any material provision of this Agreement. In the event of a resignation for Good Reason, Executive must provide the Company with a written “Notice
of Resignation for Good Reason.” The “Notice of Resignation for Good Reason” shall include the specific section of this Agreement which was relied upon and the reason that the Company’s act or failure to act has given rise to the
Executive’s resignation for Good Reason. 
  
 3.2
Termination Without Cause or Resignation with Good Reason. 
  
 a) Executive may terminate this Agreement by giving the Company written notice of such termination in accordance with Section 6.2 at least 90 days prior to the termination date, unless a shorter period is agreed upon between the parties.

  
 b) In the event at any time of (i) the termination of the
employment of the Executive without Cause (for any reason other than by Death or Disability) or (ii) the resignation of the Executive from the Company within 30 days of an event constituting Good Reason, the Company shall pay or provide to the
Executive only the following: 
  
 (i) Any earned and accrued but
unpaid installment of base salary through the date of the Executive’s resignation or termination at the rate in effect immediately prior to such resignation or termination (or the rate in effect immediately prior to the occurrence of an event
that constitutes Good Reason, whichever is greater) and all other unpaid amounts to which the Executive is entitled as of such date under any compensation plan or program of the Company (including payment for any vacation time not taken during the
year in which termination occurs and the living allowance as provided in section 2.5 b) for the period through the date of the Executive’s resignation or termination, such payments to be made in a lump sum within 15 days following the date of
resignation or termination; and 
  
 (ii) The amount the Executive
would have been entitled to pursuant to Section 2.2(a), had Executive remained employed through the end of the Fiscal Year in which termination occurs, multiplied 

 by a fraction, the numerator of which is the number of days from the beginning of such Fiscal Year to the date of
termination, and the denominator of which is 365, such amount to be paid no later than the time annual bonuses are paid to other executives of the Company; and 
  

(iii) In lieu of any further salary payments to the Executive for periods subsequent to her date of resignation or termination, the Executive will
receive six (6) months of salary continuation at the same rate of base salary and the living allowance as provided for in section 2.5 b) in effect immediately prior to the Executive’s resignation or termination (or the base salary in effect
immediately prior to the occurrence of an event that constitutes Good Reason, whichever is greater). The Company will make the salary continuation payments, less applicable taxes and other withholding, on the Company’s regular payroll dates. In
the event the Company terminates the Executive without cause, the Company may at its sole discretion, require the Executive to continue providing services for a three (3) month working notice period while said salary continuation payments are being
made; and 
  
 (iv) The company shall maintain in full force and
effect for the period described in Section 3.2(b)(iii), following the date of the Executive’s resignation or termination, health and dental programs (not life or disability programs) in which the Executive was entitled to participate either
immediately prior to the Executive’s resignation or termination or immediately prior to the occurrence of an event that constitutes Good Reason, provided that the Executive’s continued participation is possible under the general terms and
provisions of such plans and programs. If applicable, to the extent Cobra is available, the Company’s obligations are satisfied by paying the Executive’s monthly premiums for the period described in Section 3.2(b)(iii) under Cobra, and
then the Executive may continue the Cobra coverage at the Executive’s expense. 
  
 (v) As a condition to her entitlement to receive termination payments under subsections (ii) – (iv) of this Section, the Executive shall have executed and delivered to the Company a release substantially in the
form attached hereto as Exhibit A. 
  
 c) Notwithstanding the
foregoing, in the event the aggregate amount of all payments that the Executive would receive pursuant to Section 3.2(b) plus payment to be made to the Executive outside this Agreement would result in an excess “parachute payment” (as
defined in Section 280G(b)(2) of the Code) but for this Section 3.2(b), as determined in good faith by the Company, the aggregate amount of the payments required to be paid to the Executive pursuant to this Section 3.2(b) shall be reduced to the
largest amount that would result in no portion of any payment to the Executive being subject to the excise tax imposed by Section 4999 of the Code. 
  
 For greater clarity, no other payment whatsoever shall be due by the Company to the Executive. 
  
 3.3 Termination for Cause, Disability, Death or Resignation without Good Reason. In the event of the Executive’s
termination of employment for Cause, Death or Disability or his resignation without Good Reason, only the amounts set forth in clause (i) of Section 3.2(b) shall be payable to the Executive, provided that in the event of Death, the amount set forth
in clause (ii) of Section 3.2(b) shall be payable as well. 
  
 3.4
Withholding. The Company shall have the right to deduct from any amounts payable under this Agreement an amount necessary to satisfy its obligation, under applicable laws, to withhold income or other taxes of the Executive attributable to
payments made hereunder. 
  

	4.	Non-Competition/Confidentiality 

  
 4.1 The Executive agrees that during the Executive’s employment with the Company, and for a six-month period thereafter, the Executive will not,
directly or indirectly, do or suffer any of the following: 
  
 a)
Own, manage, control or participate in the ownership, management or control of, or be employed or engaged by or otherwise affiliated or associated (collectively, “Employed”) as a consultant, independent contractor or otherwise with, any
other corporation, partnership, proprietorship, firm, association, or other business entity, or otherwise engage in any business, which is engaged in any manner in, or otherwise competes with, the business of the Company or any of its affiliates (as
conducted on the date the Executive ceases to be employed by the Company in any capacity, including as a consultant) (a “Prohibited 

 Business”) in the United States of America or any of the foreign countries in which the Company or any of its
affiliates is doing business (a “Competing Business”) for so long as this Section 4.1(a) shall remain in effect, nor solicit any person or business that was at the time of the Executive’s termination of employment, or within one year
prior thereto, a customer or supplier of the Company or any of its affiliates; provided, however, that, notwithstanding the foregoing, the Executive shall not be deemed to be Employed by a Competing Business if the Board or a committee of the Board
determines that the Executive has established by clear and convincing evidence all of the following: (A) such entity (including its affiliates in aggregate) does not derive Material Revenues (as defined below) from the aggregate of all Prohibited
Businesses, (B) such entity (including its affiliates in aggregate) is not a Competitor (as defined below) of the Company and its affiliates and (C) Executive has no direct responsibility for or otherwise with respect to any Prohibited Business; for
purposes of this clause (a), “Material Revenues” shall mean that 5% or more of the revenues of the entity (including its affiliates in aggregate) are derived from the aggregate of all Prohibited Businesses; an entity shall be deemed a
“Competitor” of the Company and its affiliates if the combined gross receipts of the entity (including its affiliates in aggregate) from any Prohibited Business is more than 25% of the gross receipts of the Company and its affiliates in
such Prohibited Business; and an “affiliate” of an entity is any entity controlled by, controlling or under common control with the entity; 
  
 b) Employ, assist in employing, or otherwise associate in business with any present executive, officer, employee or agent of the Company or its
affiliates; 
  
 c) Induce any person who is an executive, officer,
employee or agent of the Company, or any member of the Company or its affiliates, to terminate their relationship with the Company or any of its affiliates; and 
  

d) Disclose, divulge, discuss, copy or otherwise use or suffer to be used in any manner, in competition with, or contrary to the interests of, the
Company, or any member of the Company or its affiliates, the customer lists, manufacturing and marketing methods, product research or engineering data, vendors, contractors, financial information, business plans and methods or other confidential
business information or trade secrets of the Company, or any member of the Company or its affiliates, it being acknowledged by the Executive that all such information regarding the business of the Company or its affiliates compiled or obtained by,
or furnished to, the Executive while the Executive shall have been employed by or associated with the Company is confidential information and the Company’s exclusive property (it being understood, however, that the information publicly
disclosed by the Company shall not be subject to this Section 4.1(d), provided that such information may not be used in connection with any of the activities prohibited under clauses (a), (b) and (c) of this Section 4.1 for so long as such clauses
remain in effect). 
  
 4.2 Upon the termination of the
Executive’s employment with the Company, or at any time upon the request of the Company, the Executive (or the Executive’s heirs or personal representatives) shall deliver to the Company (a) all documents and materials (including, without
limitation, computer files) containing confidential information relating to the business and affairs of the Company and its direct and indirect subsidiaries, and (b) all documents, materials and other property (including, without limitation,
computer files) belonging to the Company or its direct or indirect subsidiaries, which in either case are in the possession or under the control of the Executive (or Executive’s heirs or personal representatives). 
  
 4.3 The Executive expressly agrees and understands that the remedy at law for
any breach by the Executive of any of the provisions of this Section 4 will be inadequate and that damages flowing from such breach are not readily susceptible to being measured in monetary terms. Accordingly, it is acknowledged that upon adequate
proof of the Executive’s violation of any legally enforceable provision of this Section 4, the Company shall be entitled to immediate injunctive relief and may obtain a temporary order restraining any threatened or further breach. Nothing in
this Section 4 shall be deemed to limit the Company’s remedies at law or in equity for any breach by the Executive of any of the provisions of this Section 4, which may be pursued or availed of by the Company. 
  
 4.4 In the event the Executive shall violate any legally enforceable
provision of this Section 4 as to which there is a specific time period during which he/she is prohibited form taking certain actions or from engaging in certain activities, as set forth in such provision, then, such violation shall toll the running
of such time period from the date of such violation until such violation shall cease; provided, however, the Company shall seek appropriate remedies in a reasonably prompt manner after discovery of a violation by the Executive. 

 4.5 The Executive has carefully considered the nature and extent of the restrictions upon him/her and the
rights and remedies conferred upon the Company under this Section 4, and hereby acknowledges and agrees that the same are reasonable in time and territory, are designed to eliminate competition which otherwise would be unfair to the Company, are
designed to not stifle the inherent skill and experience of the Executive, would not operate as a bar to the Executive’s sole means of support, are fully required to protect the legitimate interests of the Company and do not confer a benefit
upon the Company disproportionate to the detriment to the Executive. 
  
 4.6 If any decision maker determines that any of the covenants contained in this Section 4 (the “Restrictive Covenants”), or any part thereof, is unenforceable because of the duration or geographical scope of such provision, the
duration or scope of such provision, as the case may be, shall be reduced so that such provision becomes enforceable and, in its reduced form, such provision shall then be enforceable and shall be enforced. 
  
 4.7 The Company and the Executive intend to and hereby confer jurisdiction to
enforce the Restrictive Covenants upon the courts of any jurisdiction within the geographical scope of the Restrictive Covenants. If the courts of any one or more or such jurisdictions hold the Restrictive Covenants wholly unenforceable by reason of
breach of scope or otherwise, it is the intention of the Company and the Executive that such determination not bar or in any way affect the Company’s right to the relief provided above in the courts of any other jurisdiction within the
geographical scope of such Restrictive Covenants as to breaches of such Restrictive Covenants in such other respective jurisdiction, such Restrictive Covenants as they relate to each jurisdiction being, of this purpose, severable, diverse and
independent covenants, subject, where appropriate, to the doctrine of res judicata. 
  
 The term “affiliates” in this Section 4 when used in referencing affiliates of the Company includes, but is not limited to, Henry J. Birks & Sons, Inc. 
  
 5. Assignment. The rights and obligations of the parties under this Agreement
shall not be assignable by either the Company or the Executive, provided that this Agreement is assignable by the Company to any affiliate of the Company, to any successor in interest to the business of any of the Company, or to a purchaser of all
or substantially all of the assets of any of the Company.  
  
 6.
Miscellaneous. 
  
 6.1 Governing Law. This
Agreement shall be construed in accordance with and governed for all purposes by the laws of the State of Florida. 
  
 6.2 Notices. Any notice, request, or instruction to be given hereunder shall be in writing and shall be deemed given when personally delivered or
three days after being sent by United States certified mail, postage prepaid, with return receipt requested to, the parties at their respective addresses set forth below: 
  

	 	a)	To the Company: 

  
 Mayor’s Jewelers, Inc. 
 14051
Northwest 14th Street 
 Sunrise, Florida 33323 
  
 Attention: Senior Vice President & CAO 
  

	 	b)	To the Executive: 

  
 6.3 Severability. If any paragraph, subparagraph or provision hereof is found for any reason whatsoever to be invalid or inoperative, that
paragraph, subparagraph or provision shall be deemed severable and shall not affect the force and validity of any other provision of this Agreement. If any covenant herein is determined by a court to be overly broad thereby making the covenant
unenforceable, the parties agree and it is their desire that such court shall substitute a reasonable judicially enforceable limitation in place of the offensive part of the covenant 

 and that as so modified the covenant shall be as fully enforceable as if set forth herein by the parties themselves in
the modified form. The covenants of the Executive in this Agreement shall each be construed as an agreement independent of any other provision in this Agreement, and the existence of any claim or cause of action of the Executive against the Company,
whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants in this Agreement. 
  
 6.4 Entire Agreement, Amendment and Waiver. This Agreement constitutes the entire agreement and supersedes all prior agreements of the parties
hereto relating to the subject matter hereof, and there are no oral terms or representations made by either party other than those herein. This Agreement may not be amended, supplemented or waived except by a writing signed by the party against
which such amendment or waiver is to be enforced. The waiver by any party of a breach of any provision of this Agreement shall not operate to, or be construed as a waiver of, any other breach of that provision nor as a waiver of any breach of
another provision. 
  
 6.5 Arbitration of disputes. Any
controversy or claim arising out of or relating to this Agreement, or breach thereof (other than those arising under Section 4, to the extent necessary for the Company to avail itself of the rights and remedies provided under Section 4), or any
controversy or claim arising out of the Executive’s employment with the Company, shall be submitted to arbitration in Broward County, Florida in accordance with the Rules of the American Arbitration Association, and judgment upon the award may
be entered in any court having jurisdiction thereof, provided, however, that the parties agree that (i) the panel of arbitrators shall be prohibited from disregarding, adding to or modifying the terms of this Agreement; (ii) the panel of arbitrators
shall be required to follow established principles of substantive law and the law governing burdens of proof; (iii) only legally protected rights may be enforced in arbitration; (iv) the chairperson of the arbitration panel shall be an attorney
licensed to practice law in Florida who has experience in similar matters; and (v) any demand for arbitration made by either party must be filed and served, if at all, within 365 days of the occurrence of the act or omission complained of, except
where the applicable statute of limitations exceeds this time period in which case the period provided under the statute of limitations will apply. The award rendered in any arbitration proceeding held under this Section shall be final and binding,
and judgment upon the award may be entered in any court having jurisdiction thereof, provided that the judgment conforms to established principles of law and is supported by substantial record evidence. 
  
 6.6 Enforcement. 
  
 a) This Agreement shall inure to the benefit of and be enforceable by the
Executive’s personal and legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Executive should die while any amounts are still payable to the Executive hereunder, all such amounts
shall be paid in accordance with the terms of this Agreement to the Executive’s estate or beneficiary 
  
 b) In the event proceedings are initiated by either party to enforce the provisions of this Agreement, each party shall be responsible for paying its own
costs, expenses and attorney’s fees related to or connected with the proceedings. 
  
 6.7 Survival of Rights and Obligations. All rights and obligations of the Executive or the Company arising during the term of this Agreement shall continue to have full force and effect after the date that this
Agreement terminates or expires. 
  
 6.8 Counterparts. This
Agreement may be executed in two counterparts, each of which is an original but which shall together constitute one and the same instrument. 
  
 6.9 Written Resignation. In the event this Agreement is terminated for any reason (except by death), the Executive agrees that if at the time
Executive is a director or officer of the Company or any of its direct or indirect subsidiaries, Executive will immediately deliver a written resignation as such director or officer, such resignation to become effective immediately. 
  
 6.10 Executive’s Representations. The Executive represents and
warrants to the Company that (i) the Executive is able to perform fully the Executive’s duties and responsibilities contemplated by this Agreement and (ii) there are no restrictions, covenants, agreements or limitations of any kind on his right
or ability to enter into and fully perform the terms of this Agreement. 

 Execution 
  
 Upon execution below by both parties, this Agreement will enter into full force and effect as of April 1, 2005. 
  

			
	MAYOR’S JEWELERS, INC.
		
	By:	 	  

	
	EXECUTIVE
		
	By:	 	 /s/ Thomas A. Andruskevich

 EXHIBIT A 
  

RELEASE 
  
 Mayor’s Jewelers, Inc. (the “Company”) and Daisy S. Chin-Lor (the “Executive”) entered into an Employment Agreement
(“Employment Agreement”) dated April 1, 2005. To satisfy the requirement of Section 3.2(b) of the Employment Agreement, Executive hereby grants Company the Release set forth below: 
  
 1. Release. The Executive, for herself, her heirs, and personal and
legal representatives, except as provided in Section 2 hereof, does hereby irrevocably and unconditionally release, remise, and forever discharge Company and each of their respective officers, directors, and employees (the “Releasees”),
however denominated, past, present, and future, and their predecessors, successors, and assigns, of and from any and all manner of actions, causes, matters, suits, dues, bonds, judgments, debts, accounts, covenants, agreements, claims,
controversies, guarantees, warranties, damages, liabilities, or demands of any nature whatsoever in law or equity, whether or not now known to him that he ever had, now has, or hereafter can, shall, or may have, for, upon, or by reason of any
matter, action, omission to act, transaction, practice, conduct, cause, or thing of any kind whatsoever from the beginning of the world to the date he executes this Release. Such release, remise, and discharge of the Releasees includes, without
limitation, any and all claims under any and all federal and state statutes or common law and extends without limitation to any and all acts, practices, or conduct by the Releasees, or the effects thereof, whether or not Executive now has knowledge
thereof, or if any such effects exist or may in the future exist as a result of any act, omission, practice, or conduct that occurred prior to the date he executes this Release. Except as provided in Section 2, this Release shall specifically
include, but not be limited to, the following: 
  
 (a) any and
all claims and matters of any kind which arise or might arise, or which otherwise relate to the Executive’s employment with the Company or any of the Company’s parent companies, subsidiaries, affiliates, or the Executive’s termination
of employment; 
  
 (b) any and all claims for wages and benefits
(including without limitation salary, stock, stock options, commissions, bonuses, severance pay, health and welfare benefits, vacation pay, and any other fringe-type benefit); 
  
 (c) any and all claims for wrongful discharge, breach of contract (whether written or oral, express or implied), and implied
covenants of good faith and fair dealing; 
  
 (d) any and all
claims for alleged employment discrimination on the basis of age, race, color, religion, sex, national origin, veteran status, disability and/or handicap, in violation of any federal, state, or local statute, ordinance, judicial precedent, or
executive order, including but not limited to claims for discrimination under the following statutes: Title VII of the Civil Rights Act of 1964, 42 U.S.C.§2000 et seq., the Civil Rights Act of 1866, 42 U.S.C. §1981, the Age
Discrimination in Employment Act, 29 U.S.C. §621 et seq., the Older Workers Benefit Protection Act, the Rehabilitation Act of 1972, 29 U.S.C. §701 et seq., and the Americans with Disabilities Act, 42 U.S.C. §1201 et
seq.; 
  
 (e) any and all claims under any federal or state
statute relating to employee benefits; 
  
 (f) any and all claims
in tort, including but not limited to any claims for fraud, misrepresentation, defamation, interference with contract or prospective economic advantage, intentional infliction of emotional distress, and/or negligence; 
  
 (g) any and all claims for additional commissions, compensation, or damages
of any kind; and 
  
 (h) any and all claims for attorneys’
fees and costs. 
  
 2. Limitation on Release. This Release
shall have no applicability to payments under Section 3.2(b) of the Employment Agreement or benefits payable under the terms of any written “employee benefit plan” within the meaning of the Employee Retirement Income Security Act of 1974,
as amended. 
  
 3. Review and Revocation. The Executive
acknowledges that he has had the opportunity to review the Employment Agreement and this Release and to consider their terms with his attorneys and advisors and that he understands their meaning and effect. The Executive hereby acknowledges that the
execution of this Release is the Executive’s own free and voluntary act and that the only inducement for Executive’s granting this Release is the payment provided for in Section 3.2(b) of the Employment Agreement. Executive has twenty-one
(21) days from the date of distribution of this Release to him to review it and seven (7) days after the execution date of this Release to revoke it. This Release shall not be effective unless and until Executive executes it and the seven-day period
has expired. 

 MAYOR’S JEWELERS, INC. 
  

					
	 By:
	 	 /s/ Thomas A. Andruskevich

	 	

	 	 	 	 	Date
	 Its:
	 	Chairman of the Board, President and Chief	 	 
	 	 	Executive Officer	 	 
	  
  

	 	  
  

	 Witness
	 	Date
		
	 UNDERSTOOD AND AGREED:
	 	 
		
	 /s/ Daisy Chin-Lor

	 	

	 Daisy Chin-Lor
	 	Date
	  
  

	 	  
  

	 Witness
	 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]